Jones Trading Maintains Buy on Definium Therapeutics, Raises Price Target to $90
Benzinga Newsdesk 2 months ago
NewsPrice TargetAnalyst Ratings
Jones Trading analyst Justin Walsh maintains Definium Therapeutics (NASDAQ:DFTX) with a Buy and raises the price target from $74 to $90.
Jones Trading analyst Justin Walsh maintains Definium Therapeutics (NASDAQ:DFTX) with a Buy and raises the price target from $74 to $90.